Biostage (BSTG) Short Interest Ratio & Short Volume

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free BSTG Stock Alerts

$4.45

0.00 (0.00%)

(As of 07/24/2023)

Compare

Stock Analysis Earnings

Biostage Short Interest Data

Current Short Volume: 100 shares
Previous Short Volume: 100 shares
Change Vs. Previous Month: No Change
Dollar Volume Sold Short: $390.00
Short Interest Ratio / Days to Cover: 0.1
Last Record Date: July 15, 2023

Outstanding Shares: 13,882,000 shares
Percentage of Shares Shorted: 0.00%
Today's Trading Volume: 0 shares
Average Trading Volume: 1,847 shares
Today's Volume Vs. Average: 0%

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Short Selling Biostage ?

Short Interest Days to Cover Short Percent of Float

BSTG Short Interest Over Time

BSTG Days to Cover Over Time

BSTG Percentage of Float Shorted Over Time

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

Biostage Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
7/15/2023	100 shares	$390.00	No Change	N/A	0.1	$3.90
6/30/2023	100 shares	$365.00	No Change	N/A	0	$3.65
6/15/2023	100 shares	$481.75	No Change	N/A	0.1	$4.82
5/31/2023	100 shares	$507.00	No Change	N/A	0	$5.07
5/15/2023	100 shares	$613.00	No Change	N/A	0.1	$6.13
4/30/2023	100 shares	$600.00	No Change	N/A	0.1	$6.00
Get the Latest News and Ratings for BSTG and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Biostage and its competitors with MarketBeat's FREE daily newsletter.
4/15/2023	100 shares	$640.00	-66.7%	N/A	0.1	$6.40
3/31/2023	300 shares	$1,935.00	-80.0%	N/A	0.1	$6.45
3/15/2023	1,500 shares	$8,715.00	+1,400.0%	N/A	0.2	$5.81
2/28/2023	100 shares	$600.00	No Change	N/A	0	$6.00
2/15/2023	100 shares	$625.00	-50.0%	N/A	0	$6.25
1/31/2023	200 shares	$1,140.00	-85.7%	N/A	0.1	$5.70
1/15/2023	1,400 shares	$8,260.00	-6.7%	N/A	1.8	$5.90
12/30/2022	1,500 shares	$8,250.00	No Change	N/A	0.6	$5.50
12/15/2022	1,500 shares	$9,975.00	-71.7%	N/A	0.4	$6.65
11/30/2022	5,300 shares	$37,100.00	-18.5%	N/A	2	$7.00
11/15/2022	6,500 shares	$40,950.00	+44.4%	N/A	3.6	$6.30
10/31/2022	4,500 shares	$27,675.00	No Change	N/A	1.1	$6.15
10/15/2022	4,500 shares	$27,225.00	+2.3%	N/A	0.6	$6.05
9/30/2022	4,400 shares	$31,240.00	No Change	N/A	0.8	$7.10
9/15/2022	4,400 shares	$25,564.00	-10.2%	N/A	1.6	$5.81
8/31/2022	4,900 shares	$30,380.00	No Change	N/A	0.6	$6.20
8/15/2022	4,900 shares	$22,295.00	No Change	N/A	9.8	$4.55
7/31/2022	4,900 shares	$26,460.00	No Change	N/A	4.1	$5.40
7/15/2022	4,900 shares	$24,500.00	-2.0%	N/A	0.6	$5.00
6/30/2022	5,000 shares	$23,250.00	-2.0%	N/A	8.3	$4.65
6/15/2022	5,100 shares	$22,950.00	No Change	N/A	6.4	$4.50
5/31/2022	5,100 shares	$26,112.00	No Change	N/A	12.8	$5.12
5/15/2022	5,100 shares	$28,050.00	No Change	N/A	1.1	$5.50
4/30/2022	5,100 shares	$30,600.00	No Change	N/A	0.6	$6.00
4/15/2022	5,100 shares	$30,498.00	No Change	N/A	0.9	$5.98
3/31/2022	5,100 shares	$24,990.00	No Change	N/A	1.2	$4.90
3/15/2022	5,100 shares	$20,400.00	-7.3%	N/A	2.6	$4.00
2/28/2022	5,500 shares	$24,200.00	+5.8%	N/A	2.1	$4.40
2/15/2022	5,200 shares	$23,712.00	+2.0%	N/A	1.8	$4.56
1/31/2022	5,100 shares	$19,890.00	-10.5%	N/A	0.6	$3.90
1/15/2022	5,700 shares	$26,220.00	+375.0%	N/A	0.3	$4.60
12/31/2021	1,200 shares	$2,760.00	-25.0%	N/A	0.4	$2.30
12/15/2021	1,600 shares	$4,512.00	+1,500.0%	N/A	0.3	$2.82
11/30/2021	100 shares	$198.00	No Change	N/A	0	$1.98
Tiny Biotech Stock Wins $75 Billion Patent (Ad) A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda. Find out more here >>>

BSTG Short Interest - Frequently Asked Questions

What is Biostage's current short interest?: Short interest is the volume of Biostage shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 100 shares of BSTG short. Learn More on Biostage's current short interest.
How does Biostage's short interest compare to its competitors?: Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to Biostage: enVVeno Medical Corporation (6.19%), IceCure Medical Ltd (1.76%), SEP Acquisition Corp. (0.18%), Pro-Dex, Inc. (0.63%), Sensus Healthcare, Inc. (0.26%), Asensus Surgical, Inc. (6.66%), Apyx Medical Co. (2.49%), Beyond Air, Inc. (9.71%), Daxor Co. (0.35%), Cytosorbents Co. (2.98%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($3.75 billion), Charter Communications, Inc. ($3.17 billion), Occidental Petroleum Co. ($2.86 billion), Rivian Automotive, Inc. ($2.29 billion), T. Rowe Price Group, Inc. ($2.13 billion), Royal Caribbean Cruises Ltd. ($2.05 billion), Palantir Technologies Inc. ($2.04 billion), Extra Space Storage Inc. ($1.98 billion), Enphase Energy, Inc. ($1.66 billion), and Tractor Supply ($1.61 billion). View all of the most shorted stocks.

What does it mean to sell short Biostage stock?: Short selling BSTG is an investing strategy that aims to generate trading profit from Biostage as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Biostage?: A short squeeze for Biostage occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BSTG, which in turn drives the price of the stock up even further.
How often is Biostage's short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BSTG, twice per month. The most recent reporting period available is July, 15 2023.

More Short Interest Resources from MarketBeat

Related Companies:

Short Interest Tools:

This page (OTCMKTS:BSTG) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Biostage (BSTG) Short Interest Ratio & Short Volume

Biostage Short Interest Data

BSTG Short Interest Over Time

BSTG Days to Cover Over Time

BSTG Percentage of Float Shorted Over Time

Biostage Short Interest History

BSTG Short Interest - Frequently Asked Questions

More Short Interest Resources from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info